Hookworm Vaccine Trials Begin at GW

In a pioneering study, infecting healthy adults is the next step toward eradicating the infection. “These past few months have taught me a lot about hookworms, and it’s also given me intriguing insight into my own body and behaviors,” she said. Ms. Markowitz is one of the participants of the Hookworm Study. Check out this article to read more about Ms. Markowitz's experience.

 

Latest News

Health officials have confirmed a new Ebola outbreak in the Democratic Republic of Congo’s Ituri province, where at least 65 people have died and 246 suspected cases have been identified. Authorities are especially concerned because the outbreak may involve a non-Zaire strain of the virus, meaning…
The GW VRU is a site for a clinical trial to examine Pfizer's new C. diff vaccine.
This was a phase 2, randomized, open-label, non-placebo controlled trial to evaluate two partial doses o the Modified Vaccinia Ankara-Bavarian Nordin (MVA-BN) vaccine for protection against mpox.